79 related articles for article (PubMed ID: 22578454)
1. Synthesis of PECAM-1-specific 64Cu PET imaging agent: evaluation of myocardial infarction caused by ischemia-reperfusion injury in mouse.
Xiao L; Zhang Y; Yang Z; Xu Y; Kundu B; Chordia MD; Pan D
Bioorg Med Chem Lett; 2012 Jun; 22(12):4144-7. PubMed ID: 22578454
[TBL] [Abstract][Full Text] [Related]
2. 64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
Kim H; Lee SJ; Davies-Venn C; Kim JS; Yang BY; Yao Z; Kim I; Paik CH; Bluemke DA
Nucl Med Commun; 2016 Feb; 37(2):188-96. PubMed ID: 26488428
[TBL] [Abstract][Full Text] [Related]
3. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
[TBL] [Abstract][Full Text] [Related]
4. ImmunoPET, [
Srideshikan SM; Brooks J; Zuro D; Kumar B; Sanchez J; Echavarria Parra L; Orellana M; Vishwasrao P; Nair I; Chea J; Poku K; Bowles N; Miller A; Ebner T; Molnar J; Rosenthal J; Vallera DA; Wong JYC; Stein AS; Colcher D; Shively JE; Yazaki PJ; Hui SK
Clin Cancer Res; 2019 Dec; 25(24):7463-7474. PubMed ID: 31548348
[TBL] [Abstract][Full Text] [Related]
5. Site-Specific Immuno-PET Tracer to Image PD-L1.
Wissler HL; Ehlerding EB; Lyu Z; Zhao Y; Zhang S; Eshraghi A; Buuh ZY; McGuth JC; Guan Y; Engle JW; Bartlett SJ; Voelz VA; Cai W; Wang RE
Mol Pharm; 2019 May; 16(5):2028-2036. PubMed ID: 30875232
[TBL] [Abstract][Full Text] [Related]
6. Validation of 64Cu-DOTA-rituximab injection preparation under good manufacturing practices: a PET tracer for imaging of B-cell non-Hodgkin lymphoma.
Natarajan A; Arksey N; Iagaru A; Chin FT; Gambhir SS
Mol Imaging; 2015; 14():. PubMed ID: 25762106
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
[TBL] [Abstract][Full Text] [Related]
8. Production and applications of copper-64 radiopharmaceuticals.
Sun X; Anderson CJ
Methods Enzymol; 2004; 386():237-61. PubMed ID: 15120255
[No Abstract] [Full Text] [Related]
9. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
10. Imaging of VEGF receptor in a rat myocardial infarction model using PET.
Rodriguez-Porcel M; Cai W; Gheysens O; Willmann JK; Chen K; Wang H; Chen IY; He L; Wu JC; Li ZB; Mohamedali KA; Kim S; Rosenblum MG; Chen X; Gambhir SS
J Nucl Med; 2008 Apr; 49(4):667-73. PubMed ID: 18375924
[TBL] [Abstract][Full Text] [Related]
11. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
[TBL] [Abstract][Full Text] [Related]
12. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
13. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts.
Paudyal B; Paudyal P; Oriuchi N; Hanaoka H; Tominaga H; Endo K
Cancer Sci; 2011 Jan; 102(1):117-21. PubMed ID: 21070475
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model.
Petersen AL; Binderup T; Jølck RI; Rasmussen P; Henriksen JR; Pfeifer AK; Kjær A; Andresen TL
J Control Release; 2012 Jun; 160(2):254-63. PubMed ID: 22245688
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium.
Rossin R; Muro S; Welch MJ; Muzykantov VR; Schuster DP
J Nucl Med; 2008 Jan; 49(1):103-11. PubMed ID: 18077519
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.
Wu Y; Zhu H; Zhang B; Liu F; Chen J; Wang Y; Wang Y; Zhang Z; Wu L; Si L; Xu H; Yao T; Xiao S; Xia Q; Zhang L; Yang Z; Zhou D
Bioconjug Chem; 2016 Oct; 27(10):2460-2468. PubMed ID: 27617674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
